Evidence map›Paper›PMID 26451836›Full record

ArticlePloS one2015

Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-β-Lactamase from Pseudomonas stutzeri.

Michael P S Booth, Magda Kosmopoulou, Laurent Poirel, Patrice Nordmann, James Spencer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. First report of a DIM-1-producingAntimicrobial agents and chemotherapy · 2025
    Article
  2. Article
  3. Antibiotic ResistantFoods (Basel, Switzerland) · 2019
    Review
  4. Emergence of IntI1 associated blaEmerging microbes & infections · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Michael P S BoothSchool of Cellular and Molecular Medicine, University of Bristol Medical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.
Magda KosmopoulouSchool of Cellular and Molecular Medicine, University of Bristol Medical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.
Laurent PoirelMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Rue Albert Gockel 3, CH-1700, Fribourg, Switzerland.
Patrice NordmannMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Rue Albert Gockel 3, CH-1700, Fribourg, Switzerland.
James SpencerSchool of Cellular and Molecular Medicine, University of Bristol Medical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.
University of Bristol · GBUniversity of Fribourg · CH

Funding

A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
Medical Research Council G1100135NIAID NIH HHS 1R01AI100560-01NIAID NIH HHS R01 AI100560
6 · The paper itself

Abstract

Metallo-β-lactamases (MBLs) hydrolyze almost all classes of β-lactam antibiotic, including carbapenems-currently first choice drugs for opportunistic infections by Gram-negative bacterial pathogens. MBL inhibitor development is complicated by the diversity within this group of enzymes, and by the appearance of new enzymes that continue to be identified both as chromosomal genes and on mobile genetic elements. One such newly discovered MBL is DIM-1, a mobile enzyme originally discovered in the opportunist pathogen Pseudomonas stutzeri but subsequently identified in other species and locations. DIM-1 is a subclass B1 MBL more closely related to the TMB-1, GIM-1 and IMP enzymes than to other clinically encountered MBLs such as VIM and NDM; and possesses Arg, rather than the more usual Lys, at position 224 in the putative substrate binding site. Here we report the crystallization and structure determination of DIM-1. DIM-1 possesses a binuclear metal center with a 5 (rather than the more usual 4) co-ordinate tri-histidine (Zn1) site and both 4- and 5-co-ordinate Cys-His-Asp- (Zn2) sites observed in the two molecules of the crystallographic asymmetric unit. These data indicate a degree of variability in metal co-ordination geometry in the DIM-1 active site, as well as facilitating inclusion of DIM-1 in structure-based MBL inhibitor discovery programmes.

Indexed as

Protein ConformationBacterial Proteinsbeta-LactamasesBinding SitesCrystallographyHistidineProtein IsoformsPseudomonas stutzeriZincBacterial Proteinsbeta-LactamasesHistidineProtein IsoformsZinc

Identifiers

PMID26451836
PMCPMC4599830
OpenAlexW2188372985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.